Snowball logo
logo
CLBT

Cellebrite DI Ltd. Ordinary Shares

CLBT โ€ข NASDAQ
$11.14+$0.34ย  (3.15%)
Estimate
P/E
46.4
EPS
0.24
Beta
1.176
Growth
Revenue, YoY
19.3%
Net income, YoY
-37.14%
FCF, YoY
-9.14%
Forecast
P/E (FWD)
16.9
EPS (FWD)
0.661
About the company
Ticker
CLBT
ISIN
IL0011794802
Country
Other
Sector (GICS)
Information Technology
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Frequently asked questions

What sector does Cellebrite DI Ltd. Ordinary Shares (CLBT) operate in?

Cellebrite DI Ltd. Ordinary Shares belongs to the Information Technology sector and operates in the Software - Infrastructure industry.

What is Cellebrite DI Ltd. Ordinary Shares (CLBT) current stock price?

As of the latest data, Cellebrite DI Ltd. Ordinary Shares stock price is $11.14, with a previous close of $10.80. Cellebrite DI Ltd. Ordinary Shares gained $0.34 in the last trading session, representing a 3.15% increase.

What is Cellebrite DI Ltd. Ordinary Shares (CLBT) current market capitalization?

Cellebrite DI Ltd. Ordinary Shares market cap is approximately 2.79 billion.

What is Cellebrite DI Ltd. Ordinary Shares (CLBT) Earnings Per Share (EPS)?

The trailing EPS is $0.24, and the forward EPS is $0.66.

What is Cellebrite DI Ltd. Ordinary Shares (CLBT) Price-to-Earnings (P/E) ratio?

Cellebrite DI Ltd. Ordinary Shares current P/E ratio is 46.42, with a forward P/E of 16.85.

What is Cellebrite DI Ltd. Ordinary Shares (CLBT) EBITDA?

Cellebrite DI Ltd. Ordinary Shares EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 20.64 million.

Does Cellebrite DI Ltd. Ordinary Shares (CLBT) pay dividends?

No. Cellebrite DI Ltd. Ordinary Shares does not pay a dividend.

How did Cellebrite DI Ltd. Ordinary Shares (CLBT) perform in its most recent earnings report?

In the last report (June 30, 2026), Cellebrite DI Ltd. Ordinary Shares posted an EPS surprise of 20% and a revenue surprise of 1%.

What is Cellebrite DI Ltd. Ordinary Shares (CLBT) beta (volatility) score?

Cellebrite DI Ltd. Ordinary Shares has a beta of 1.176, meaning its volatility is roughly in line with the market.